GMF78 Profile picture
Jan 7, 2023 26 tweets 8 min read Read on X
$PRTG new investor presentation out this week, worth a look through 🧵 1/26
2/26 legal disclaimer
3/26 $PRTG Investment Highlights
4/26 $PRTG Proven Leadership with #oncology and #financing expertise
5/26 $PRTG - Formula for Success
6/26 $PRTG #iNKT #agonists PORT-2, PORT-3, activating the innate, adaptive immune system and correcting the TMW
7/26 $PRTG PORT-2 - Rationally Designed Liposomal Formulation of IMM60 - #cytokine release
8/26 $PRTG PORT-2 Stimulates multiple arms of the immune system to produce a robust anti-cancer response
9/26 $PRTG - multiple cell types involved with anti-cancer response
10/26 $PRTG PORT-2 demonstrates superior response versus PD-1 antibody
11/26 $PRTG Interim P1 data confimed PORT-2 activity and showed good safety (#SITC2022)
12/26 $PRTG P2 evaluates front line NSCLC and refractory melanoma
13/26 $PRTG - #adenosine portfolio PORT-6 PORT-7 PORT-8 PORT-9
14/26 $PRTG - leveraging A2A and A2B alone or in combo allows for customization of treatment
15/26 $PRTG - Difference in A2A small molecules
16/26 $PRTG - fast follower with superior profile offers major competitive advantages
17/26 $PRTG - PORT-7 highly selective and potent A2B adenosine receptor antagonist
18/26 $PRTG - PORT-601 Adaptive P1a/P1b study
19/26 $PRTG - strong US and global IP positions on platforms and products
20/26 $PRTG 9 P1b/P2 data catalysts anticipated to drive value 2023/4
21/26 $PRTG summary financial data
22/26 $PRTG accelerating I/O development in untapped growth areas
23/26 $PRTG Appendix (man pretending to be busy for stock photo opportunity)
24/26 $PRTG - IMPORT-201 dose escalation with best in class design for NSCLC and #melanoma
25/26 $PRTG PORT-6 potential best in class A2A, better selectivity, potency and durability.
26/26 $PRTG - upcoming clinical development milestones

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with GMF78

GMF78 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @GMF782

Mar 4, 2023
$VLE Valeura Energy - a 🧵of their investor presentation, shows why the stock deserves to be on your radar, due to close the Mubadala acquisition this month. 24100 bopd on the way, US$33m/mth positive cashflow, wonder how long before a #divi stock... 1/15
$VLE 2/15
$VLE 3/15
Read 15 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(